SEC Filing Document

Company: Berto Acquisition Corp. II
Ticker: GUAC
CIK: 2081515
Filing Type: S-1/A
Document Type: EX-1.1
Date Filed: 2026-05-12
Accession Number: 0001829126-26-005001
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2081515/000182912626005001/bertoacquisition2_ex1-1.htm

Chunk 2 of 22
Word Count: 1419
Character Count: 9227

Document Content:

held in the Trust Account, and the Deferred Underwriting Commission (as defined in the following sentence, which is up to the Maximum Deferred Underwriting Commission) shall be payable directly from the Trust Account, without accrued interest, to the Representative for its own account and the account of the Underwriters upon the consummation of the initial Business Combination (as defined below), subject, in each case, to the reductions provided for in this Section 1.3. The Representative, on behalf of itself and the Underwriters, agrees that the Deferred Underwriting Commission will be 3.9% of funds available in the Trust Account after payments made out of the Trust Account to honor redemption rights of the Public Shareholders and less any funds sourced by the Sponsor or other holders of Founder Shares (as defined below) or any cash remaining in the Trust Account pursuant to structured agreements such as forward purchase agreements, non-redemption agreements,

any agreements or
arrangements alike, or any other incentivization provided to the Public Shareholders to not redeem. The Trust Agreement shall
provide that the Trustee is required to obtain a written instruction signed by the Company and acknowledged by the Representative
with respect to the transfer of the funds held in the Trust Account, including the payment of the Deferred Underwriting Commission
from the Trust Account, prior to commencing any liquidation of the assets of the Trust Account in connection with the Business
Combination, and such provision of the Trust Agreement shall not be permitted to be amended without the prior written consent of the
Representative. In the event that the Company is unable to consummate a Business Combination and Continental, as the trustee of the
Trust Account (in this context, the “Trustee”), commences liquidation of the Trust Account as provided in the
Trust Agreement, the Representative, on behalf of itself and the Underwriters, agrees that (i) it shall forfeit any rights or claims
to the Deferred Underwriting Commission, including any accrued interest thereon; and (ii) the Deferred Underwriting Commission,
together with all other amounts on deposit in the Trust Account, shall be distributed on a pro rata basis among the Public
Shareholders. The Representative shall have the right to agree to any further modifications to the Deferred Underwriting Commission
on behalf of the Underwriters and any decisions relating to such modifications shall be made exclusively by the Representative on
behalf of itself and the Underwriters. For the avoidance of doubt, the obligations of each Underwriter under this Agreement shall be
fully satisfied upon the payment of the purchase price for the Public Securities purchased by such Underwriter on the Closing Date
or Option Closing Date, and the Underwriters shall be entitled to their portion of the Deferred Underwriting Commission without any
further conditions except for those set forth above and below. Notwithstanding anything to the contrary in this Agreement, each
Underwriter may at any time prior to the Business Combination Closing and in its sole and absolute discretion, by written notice to
the Company, elect to forfeit any right or claim to its Deferred Underwriting Commission, in which case the Company agrees to
instruct the Trustee not to pay such Underwriter its Deferred Underwriting Commission upon the Business Combination Closing. For the
avoidance of doubt, any such election by an Underwriter shall be without prejudice to any right or claim of any other Underwriter to
its respective portion of the Deferred Underwriting Commission or to any other right such Underwriter may have under this
Agreement.

1.3.2 Deferred Fee Allocation. Notwithstanding anything to the contrary contained herein, the Company shall have the sole discretion, at any time prior to the consummation of the Business Combination, to allocate up to one hundred percent (100%) of the Deferred Underwriting Commission to one or more additional capital markets co-managers, advisors, underwriters or other financial institutions that the Company elects to engage in connection with the Business Combination, on such terms as the Company may determine in its sole discretion, or to elect not to allocate, designate or pay any portion of the Deferred Underwriting Commission to any party, including the Underwriters.

1.4 Private Placements.

1.4.1 Founder Shares. In December 2025, Berto Acquisition Sponsor II LLC, a Cayman Islands limited liability company (“Sponsor”), and certain affiliates of the Sponsor, paid $23,782.61 for an aggregate of 6,837,500 Ordinary Shares, and an individual and Meteora Capital, LLC, a consultant, (each not affiliated with the Sponsor) each paid $173.91 and $1,043.48 for an aggregate of 50,000 and 300,000 Ordinary Shares, respectively, for a total of 7,187,500 Ordinary Shares (the “Founder Shares”) issued for an aggregate purchase price of $25,000, or approximately $0.003 per share, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”). No underwriting discounts, commissions or placement fees have been or will be payable in connection with the purchase of Founder Shares. Except as described in the Registration Statement, none of the Founder Shares may be sold, assigned or transferred by the holders thereof until the earlier of (A) one year following the completion of the Business Combination or earlier if, subsequent to the completion of the Business Combination, the closing price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any twenty (20) trading days within any thirty (30)-trading day period commencing at least one hundred fifty (150) days after the completion of the Business Combination, and (B) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange Ordinary Shares for cash, securities or other property, in each case, subject to standard exceptions for transfers to family members and for estate planning purposes or pursuant to other customary exceptions. The holders of Founder Shares shall have no right to any liquidating distributions with respect to any portion of the Founder Shares in the event the Company fails to consummate a Business Combination. The holders of the Founder Shares shall not have redemption rights with respect to the Founder Shares. In the event that the Over-allotment Option is not exercised in full, the Sponsor and certain affiliates of the Sponsor will be required to forfeit such number of Founder Shares (up to 937,500 Founder Shares) as described in the Registration Statement such that the Founder Shares then outstanding will comprise 20% of the issued and outstanding Public Shares after giving effect to the Offering and exercise, if any, of the Over- allotment Option (excluding the Placement Securities as defined below).

1.4.2 Warrant Private Placement. Simultaneously with the Closing Date, the Sponsor will purchase from the Company, pursuant to the Purchase Agreement (as defined in Section 2.21.2 hereof), an aggregate of 3,500,000 private placement warrants (the “Placement Warrants”), whether or not the Over-allotment Option is exercised in full or at all, which Placement Warrants are substantially identical to the Warrants included in the Firm Units, subject to certain exceptions, at a purchase price of $1.00 per Placement Warrant, in a private placement intended to be exempt from registration under the Act pursuant to Section 4(a)(2) of the Act. The private placement of the Placement Warrants to the Sponsor is referred to herein as the “Warrant Private Placement.” Certain proceeds from the sale of the Placement Warrants shall be deposited into the Trust Account. Neither the Placement Warrants nor the Ordinary Shares issuable upon exercise of the Placement Warrants (collectively, the “Placement Securities”) may be sold, assigned or transferred by the Sponsor or their permitted transferees until thirty (30) days after consummation of a Business Combination.

1.4.3 No underwriting discounts, commissions, or placement fees have been or will be payable in connection with the Placement Warrants sold in the Warrant Private Placement. The Placement Warrants are identical to the Warrants included in the Units except that (i) none of the Placement Warrants will be transferable, assignable or salable until thirty (30) days after the consummation of a Business Combination except to permitted transferees and (ii) will be entitled to registration rights. The Public Securities, the Placement Securities, and the Founder Shares are hereinafter referred to collectively as the “Securities.”

1.5 Working Capital. Upon consummation of the Offering and the Warrant Private Placement, it is intended that up to $[●] of the proceeds from the Offering and the Warrant Private Placement will be released to the Company and held outside of the Trust Account to fund the working capital requirements of the Company.